Table of Contents Global Bioengineered Proteins Drugs Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Bioengineered Proteins Drugs Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Bioengineered Proteins Drugs Segment by Type 1.2.1 Cytokines and Chemokines 1.2.2 Monoclonal Antibodies 1.2.3 Therapeutic Enzymes 1.2.4 Peptide Hormones 1.2.5 Peptide Antibiotics 1.2.6 Vaccines 1.2.7 Other 1.3 Market Analysis by Application 1.3.1 Diabetes and Hormonal Disorders 1.3.2 Genetic and Fertility Disorders 1.3.3 Cancers 1.3.4 Organ Transplants 1.3.5 Others 1.4 Overview of Global Bioengineered Proteins Drugs Market 1.4.1 Global Bioengineered Proteins Drugs Revenue (2015-2025) 1.4.2 Global Bioengineered Proteins Drugs Production and Capacity (2015-2025) 1.4.3 North America Bioengineered Proteins Drugs Status and Prospect (2015-2025) 1.4.4 Europe Bioengineered Proteins Drugs Status and Prospect (2015-2025) 1.4.5 Japan Bioengineered Proteins Drugs Status and Prospect (2014-2025) 1.4.6 China Bioengineered Proteins Drugs Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Bioengineered Proteins Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Bioengineered Proteins Drugs Industry 1.6.2 Bioengineered Proteins Drugs Business Impact Assessment - Covid-19 1.6.3 Market Trends and Bioengineered Proteins Drugs Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Bioengineered Proteins Drugs Market Competition by Manufacturer 2.1 Global Bioengineered Proteins Drugs Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Bioengineered Proteins Drugs Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Bioengineered Proteins Drugs Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Bioengineered Proteins Drugs Manufacturer Market Share 2.5 Top 10 Bioengineered Proteins Drugs Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Bioengineered Proteins Drugs Market 2.7 Key Manufacturers Bioengineered Proteins Drugs Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Bioengineered Proteins Drugs Industry Key Manufacturers 3.1 Eli Lilly 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Eli Lilly Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Eli Lilly News 3.2 F. Hoffmann-La Roche 3.2.1 Company Details 3.2.2 Product Information 3.2.3 F. Hoffmann-La Roche Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 F. Hoffmann-La Roche News 3.3 Sanofi 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Sanofi Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Sanofi News 3.4 Pfizer 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Pfizer Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Pfizer News 3.5 GlaxoSmithKline 3.5.1 Company Details 3.5.2 Product Information 3.5.3 GlaxoSmithKline Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 GlaxoSmithKline News 3.6 Novartis 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Novartis Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Novartis News 3.7 Allergan 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Allergan Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Allergan News 3.8 AbbVie 3.8.1 Company Details 3.8.2 Product Information 3.8.3 AbbVie Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 AbbVie News 3.9 Agilent Technologies 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Agilent Technologies Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Agilent Technologies News 3.10 Panacea Biotec 3.10.1 Company Details 3.10.2 Product Information 3.10.3 Panacea Biotec Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.10.4 Main Business Overview 3.10.5 Panacea Biotec News 3.11 Wockhardt 3.11.1 Company Details 3.11.2 Product Information 3.11.3 Wockhardt Bioengineered Proteins Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.11.4 Main Business Overview 3.11.5 Wockhardt News 4 Global Bioengineered Proteins Drugs Market Size Categorized by Regions (2015-2020) 4.1 Global Bioengineered Proteins Drugs Sales Market Share by Region 4.2 Global Bioengineered Proteins Drugs Revenue Market Share by Region (2015-2019) 4.3 Global Bioengineered Proteins Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Bioengineered Proteins Drugs Market Size Detail 4.4.1 North America Bioengineered Proteins Drugs Sales Growth Rate (2015-2020) 4.4.2 North America Bioengineered Proteins Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Bioengineered Proteins Drugs Market Size Detail 4.5.1 Europe Bioengineered Proteins Drugs Sales Growth Rate (2015-2020) 4.5.2 Europe Bioengineered Proteins Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Bioengineered Proteins Drugs Market Size Detail 4.6.1 Japan Bioengineered Proteins Drugs Sales Growth Rate (2015-2020) 4.6.2 Japan Bioengineered Proteins Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Bioengineered Proteins Drugs Market Size Detail 4.7.1 China Bioengineered Proteins Drugs Sales Growth Rate (2015-2020) 4.7.2 China Bioengineered Proteins Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Bioengineered Proteins Drugs Market Segment by Type 5.1 Global Bioengineered Proteins Drugs Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Bioengineered Proteins Drugs Sales and Market Share by Type (2015-2020) 5.1.2 Global Bioengineered Proteins Drugs Revenue and Market Share by Type (2015-2020) 5.2 Cytokines and Chemokines Sales Growth Rate and Price 5.2.1 Global Cytokines and Chemokines Sales Growth Rate (2015-2020) 5.2.2 Global Cytokines and Chemokines Price (2015-2020) 5.3 Monoclonal Antibodies Sales Growth Rate and Price 5.3.1 Global Monoclonal Antibodies Sales Growth Rate (2015-2020) 5.3.2 Global Monoclonal Antibodies Price (2015-2020) 5.4 Therapeutic Enzymes Sales Growth Rate and Price 5.4.1 Global Therapeutic Enzymes Sales Growth Rate (2015-2020) 5.4.2 Global Therapeutic Enzymes Price (2015-2020) 5.5 Peptide Hormones Sales Growth Rate and Price 5.5.1 Global Peptide Hormones Sales Growth Rate (2015-2020) 5.5.2 Global Peptide Hormones Price (2015-2020) 5.6 Peptide Antibiotics Sales Growth Rate and Price 5.6.1 Global Peptide Antibiotics Sales Growth Rate (2015-2020) 5.6.2 Global Peptide Antibiotics Price (2015-2020) 5.7 Vaccines Sales Growth Rate and Price 5.7.1 Global Vaccines Sales Growth Rate (2015-2020) 5.7.2 Global Vaccines Price (2015-2020) 5.8 Other Sales Growth Rate and Price 5.8.1 Global Other Sales Growth Rate (2015-2020) 5.8.2 Global Other Price (2015-2020) 6 Global Bioengineered Proteins Drugs Market Segment by Application 6.1 Global Bioengineered Proteins Drugs Sales Market Share by Application (2015-2020) 6.2 Diabetes and Hormonal Disorders Sales Growth Rate (2015-2020) 6.3 Genetic and Fertility Disorders Sales Growth Rate (2015-2020) 6.4 Cancers Sales Growth Rate (2015-2020) 6.5 Organ Transplants Sales Growth Rate (2015-2020) 6.6 Others Sales Growth Rate (2015-2020) 7 Bioengineered Proteins Drugs Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Bioengineered Proteins Drugs Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Bioengineered Proteins Drugs Market Forecast 8.1 Global Bioengineered Proteins Drugs Sales, Revenue Forecast 8.1.1 Global Bioengineered Proteins Drugs Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Bioengineered Proteins Drugs Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Bioengineered Proteins Drugs Price and Trend Forecast (2020-2025) 8.2 Global Bioengineered Proteins Drugs Sales Forecast by Region (2020-2025) 8.2.1 North America Bioengineered Proteins Drugs Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Bioengineered Proteins Drugs Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Bioengineered Proteins Drugs Production, Revenue Forecast (2020-2025) 8.2.4 China Bioengineered Proteins Drugs Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Bioengineered Proteins Drugs Picture Table Global Bioengineered Proteins Drugs Sales by Type Figure Global Sales Market Share of Bioengineered Proteins Drugs by Product Type in 2019 Table Breakdown of Bioengineered Proteins Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Figure Bioengineered Proteins Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Cytokines and Chemokines Picture Figure Monoclonal Antibodies Picture Figure Therapeutic Enzymes Picture Figure Peptide Hormones Picture Figure Peptide Antibiotics Picture Figure Vaccines Picture Figure Other Picture Table Global Bioengineered Proteins Drugs Sales by Application Figure Global Bioengineered Proteins Drugs Sales Market Share by Application in 2019 Figure Diabetes and Hormonal Disorders Picture Figure Genetic and Fertility Disorders Picture Figure Cancers Picture Figure Organ Transplants Picture Figure Others Picture Table Bioengineered Proteins Drugs Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Bioengineered Proteins Drugs Revenue (Million US$) (2015-2025) Figure Global Bioengineered Proteins Drugs Production (K Units) (2015-2025) Figure North America Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate (2014-2025) Figure China Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Bioengineered Proteins Drugs Sales by Manufacturer (2018-2020) Figure Global Bioengineered Proteins Drugs Sales Market Share by Manufacturer in 2019 Table Global Bioengineered Proteins Drugs Revenue by Manufacturer (2018-2020) Figure Global Bioengineered Proteins Drugs Revenue Market Share by Manufacturer in 2019 Table Global Bioengineered Proteins Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Bioengineered Proteins Drugs Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Bioengineered Proteins Drugs Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Bioengineered Proteins Drugs Market Table Key Manufacturers Bioengineered Proteins Drugs Product Type Table Mergers & Acquisitions Planning Table Eli Lilly Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Eli Lilly Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Eli Lilly Bioengineered Proteins Drugs Market Share (2018-2020) Table Eli Lilly Main Business Table Eli Lilly Recent Development Table F. Hoffmann-La Roche Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of F. Hoffmann-La Roche Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure F. Hoffmann-La Roche Bioengineered Proteins Drugs Market Share (2018-2020) Table F. Hoffmann-La Roche Main Business Table F. Hoffmann-La Roche Recent Development Table Sanofi Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Sanofi Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sanofi Bioengineered Proteins Drugs Market Share (2018-2020) Table Sanofi Main Business Table Sanofi Recent Development Table Pfizer Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Pfizer Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer Bioengineered Proteins Drugs Market Share (2018-2020) Table Pfizer Main Business Table Pfizer Recent Development Table GlaxoSmithKline Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of GlaxoSmithKline Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline Bioengineered Proteins Drugs Market Share (2018-2020) Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Novartis Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Novartis Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis Bioengineered Proteins Drugs Market Share (2018-2020) Table Novartis Main Business Table Novartis Recent Development Table Allergan Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Allergan Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Allergan Bioengineered Proteins Drugs Market Share (2018-2020) Table Allergan Main Business Table Allergan Recent Development Table AbbVie Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of AbbVie Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure AbbVie Bioengineered Proteins Drugs Market Share (2018-2020) Table AbbVie Main Business Table AbbVie Recent Development Table Agilent Technologies Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Agilent Technologies Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Agilent Technologies Bioengineered Proteins Drugs Market Share (2018-2020) Table Agilent Technologies Main Business Table Agilent Technologies Recent Development Table Panacea Biotec Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Panacea Biotec Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Panacea Biotec Bioengineered Proteins Drugs Market Share (2018-2020) Table Panacea Biotec Main Business Table Panacea Biotec Recent Development Table Wockhardt Company Profile Figure Bioengineered Proteins Drugs Product Picture and Specifications of Wockhardt Table Bioengineered Proteins Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Wockhardt Bioengineered Proteins Drugs Market Share (2018-2020) Table Wockhardt Main Business Table Wockhardt Recent Development Table Global Bioengineered Proteins Drugs Sales (K Units) by Region (2015-2020) Table Global Bioengineered Proteins Drugs Sales Market Share by Region (2015-2019) Figure Global Bioengineered Proteins Drugs Sales Market Share by Region (2015-2019) Figure Global Bioengineered Proteins Drugs Sales Market Share by Region in 2018 Table Global Bioengineered Proteins Drugs Revenue (Million US$) by Region (2015-2020) Table Global Bioengineered Proteins Drugs Revenue Market Share by Region (2015-2020) Figure Global Bioengineered Proteins Drugs Revenue Market Share by Region (2015-2020) Figure Global Bioengineered Proteins Drugs Revenue Market Share by Region in 2019 Table Global Bioengineered Proteins Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Bioengineered Proteins Drugs Sales (K Units) Growth Rate (2015-2020) Figure Europe Bioengineered Proteins Drugs Sales (K Units) Growth Rate (2015-2020) Table Europe Bioengineered Proteins Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Bioengineered Proteins Drugs Sales (K Units) Growth Rate (2015-2020) Table Japan Bioengineered Proteins Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Bioengineered Proteins Drugs Sales (K Units) Growth Rate (2015-2020) Table China Bioengineered Proteins Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Bioengineered Proteins Drugs Sales by Type (2015-2020) Table Global Bioengineered Proteins Drugs Sales Market Share by Type (2015-2020) Figure Global Bioengineered Proteins Drugs Sales Market Share by Type in 2019 Table Global Bioengineered Proteins Drugs Revenue by Type (2015-2020) Table Global Bioengineered Proteins Drugs Revenue Market Share by Type (2015-2020) Figure Global Bioengineered Proteins Drugs Revenue Market Share by Type in 2019 Figure Global Cytokines and Chemokines Sales Growth Rate (2015-2025) Figure Global Cytokines and Chemokines Price (2015-2020) Figure Global Monoclonal Antibodies Sales Growth Rate (2015-2025) Figure Global Monoclonal Antibodies Price (2015-2020) Figure Global Therapeutic Enzymes Sales Growth Rate (2015-2025) Figure Global Therapeutic Enzymes Price (2015-2020) Figure Global Peptide Hormones Sales Growth Rate (2015-2025) Figure Global Peptide Hormones Price (2015-2020) Figure Global Peptide Antibiotics Sales Growth Rate (2015-2025) Figure Global Peptide Antibiotics Price (2015-2020) Figure Global Vaccines Sales Growth Rate (2015-2025) Figure Global Vaccines Price (2015-2020) Figure Global Other Sales Growth Rate (2015-2025) Figure Global Other Price (2015-2020) Table Global Bioengineered Proteins Drugs Sales Market Share by Application (2015-2020) Figure Global Bioengineered Proteins Drugs Sales Market Share by Application in 2019 Figure Global Diabetes and Hormonal Disorders Sales Growth Rate (2015-2025) Figure Global Genetic and Fertility Disorders Sales Growth Rate (2015-2025) Figure Global Cancers Sales Growth Rate (2015-2025) Figure Global Organ Transplants Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Bioengineered Proteins Drugs Table Key Players of Downstream Markets Figure Sales Channel Figure Global Bioengineered Proteins Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Bioengineered Proteins Drugs Price and Trend Forecast (2020-2025) Table Global Bioengineered Proteins Drugs Sales (K Units) Forecast by Region (2020-2025) Figure Global Bioengineered Proteins Drugs Production Market Share Forecast by Region (2020-2025) Figure North America Bioengineered Proteins Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Bioengineered Proteins Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Bioengineered Proteins Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Bioengineered Proteins Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure China Bioengineered Proteins Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Eli Lilly F. Hoffmann-La Roche Sanofi Pfizer GlaxoSmithKline Novartis Allergan AbbVie Agilent Technologies